Biden team to meet vaccine firms as Trump delays handoff

Associated Press Pedestrians walk past Pfizer world headquarters in New York last week, when the company said an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19. President-elect Joe Biden’s advisors will meet with Pfizer and other pharmaceutical companies this week as the coronavirus continues to rage in the U.S.

FILE - In this Sept. 23, 2020 file photo, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, listens during a Senate Senate Health, Education, Labor, and Pensions Committee Hearing on the federal government response to COVID-19 Capitol Hill in Washington. Fauci is recommending masks at Thanksgiving gatherings if the coronavirus status of people is unknown. (Graeme Jennings/Pool via AP)

WASHINGTON — Joe Biden’s scientific advisers will meet with vaccine makers in coming days as the presidential transition remains stalled because of President Donald Trump’s refusal to acknowledge that he lost the election. That delayed handoff is especially problematic during a public health crisis, the government’s top infectious disease expert said.